Related Experiment Video

Updated: Jul 24, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Selective estrogen receptor modulators. An aid in unraveling the links between estrogen and breast cancer

S A Fuqua1, J Russo, S E Shackney

  • 1Breast Center, Baylor College of Medicine, Houston, USA. sfuqua@bcm.tmc.edu

Postgraduate Medicine
|April 12, 2001
PubMed

Insights

Selective estrogen receptor modulators (SERMs) are key in breast cancer treatment. Understanding SERM-estrogen receptor interactions reveals how estrogen impacts cell growth, aiding new targeted therapy development.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Breast cancer is a hormone-dependent malignancy influenced by estrogen.
  • The molecular mechanisms linking estrogen to cell proliferation in breast tissue remain incompletely understood.
  • Selective estrogen receptor modulators (SERMs) are crucial for breast cancer prevention and treatment.

Purpose of the Study:

  • To elucidate the complex molecular mechanisms by which estrogen influences cell proliferation in breast tissue.
  • To explore the role of SERMs in understanding estrogen's effects on cell growth.
  • To investigate the relationship between SERM structure and function for targeted therapy design.

Main Methods:

  • Competitive inhibition assays to study estrogen binding to estrogen receptors alpha and beta.
  • Structural analysis of selective estrogen receptor modulator-estrogen receptor complexes.
  • Investigation of signaling pathways affected by estrogen and SERMs.

Main Results:

  • Selective estrogen receptor modulators (SERMs) act as competitive inhibitors of estrogen at estrogen receptors alpha and beta.
  • Each SERM-estrogen receptor complex exhibits unique structural properties influencing tissue-specific activity.
  • SERM-estrogen receptor interactions provide insights into estrogen-mediated cell proliferation pathways.

Conclusions:

  • Selective estrogen receptor modulators (SERMs) are vital for breast cancer management and offer a means to study estrogen's role in cell proliferation.
  • Understanding the structure-function relationship of SERMs can illuminate estrogen signaling pathways.
  • This knowledge may facilitate the development of novel, targeted therapeutic agents for breast cancer.

More Related Videos

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: